Compliance Rate

Compliance Rate 50.0%
Compliant submissions 2
Incompliant submissions 2
Total trials 4

My Organizations' Clinical Trials

Showing 1225 of 1308 entries
View as:

Visceral Manifold Study for the Repair of Thoracoabdominal Aortic Aneurysms

Phase: N/A Priority: Normal
NCT ID: NCT03246126 Org: User:
Start: 11/01/17 End: 06/07/23 Due: 06/07/24

Understanding Poor Vaccine Responses to Hepatitis B Vaccination

Phase: N/A Priority: Normal
NCT ID: NCT04674462 Org: User:
Start: 07/07/22 End: 07/31/26 Due: 07/31/27

Anterior Orientation vs Posterior Orientation in Per Oral Endoscopic Myotomy POEM for the Treatment of Achalasia

Phase: N/A Priority: Normal
NCT ID: NCT03228758 Org: User:
Start: 07/24/17 End: 05/24/19 Due: 05/24/20

Upper Extremity Post-op Splints: Do They Improve Post-operative Pain?

Phase: N/A Priority: Normal
NCT ID: NCT03891966 Org: User:
Start: 11/08/18 End: 08/01/23 Due: 08/01/24

Split Chest Breast Neurotization

Phase: N/A Priority: Normal
NCT ID: NCT05757778 Org: User:
Start: 08/08/23 End: 04/07/27 Due: 04/07/28

Telephone-Based Support Programs for People With Epilepsy

Phase: N/A Priority: Normal
NCT ID: NCT05082181 Org: User:
Start: 11/09/21 End: 08/31/26 Due: 08/31/27

Oral Pathology Asynchronous Telementoring Pilot Study

Phase: N/A Priority: Normal
NCT ID: NCT04166214 Org: User:
Start: 07/14/20 End: 11/23/20 Due: 11/23/21

Fenfluramine in CDKL5 Deficiency Disorder (CDD)

Phase: N/A Priority: Normal
NCT ID: NCT03861871 Org: User:
Start: 10/29/19 End: 10/24/22 Due: 10/24/23

A Randomized Comparison of Rifaximin Versus Lactulose in Hospitalized Cirrhotic Patients With Renal Failure

Phase: N/A Priority: Normal
NCT ID: NCT02086825 Org: User:
Start: 10/31/15 End: - Due: -

Does Weightbearing Crutch Technology Impact Patient Compliance?

Phase: N/A Priority: Normal
NCT ID: NCT05825079 Org: User:
Start: 06/09/23 End: 06/01/25 Due: 06/01/26

Examine the Preliminary Effect of an Evidence-Based Practice (EBP) Consultation Model on Staff Fidelity to EBP

Phase: N/A Priority: Normal
NCT ID: NCT03722745 Org: User:
Start: 07/17/19 End: 07/17/19 Due: 07/17/20

Using tDCS in Speech-based Stroke Rehabilitation

Phase: N/A Priority: Normal
NCT ID: NCT03452202 Org: User:
Start: 01/11/19 End: 10/30/26 Due: 10/30/27

TRACK-MSA: A Longitudinal Study to Define Outcome Measures in Multiple System Atrophy

Phase: N/A Priority: Normal
NCT ID: NCT04450992 Org: User:
Start: 06/17/20 End: 06/19/24 Due: 06/19/25

Optimizing Timing of rhPSMA-7.3 (18F) for Assessing Site(s) of Recurrent Disease Following Radical Prostatectomy

Phase: N/A Priority: Normal
NCT ID: NCT05678322 Org: User:
Start: 01/31/23 End: 11/30/25 Due: 11/30/26

Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Glioblastoma Multiforme or Brain Stem Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00002619 Org: User:
Start: 09/30/94 End: - Due: -

Black Church Treatment Study

Phase: N/A Priority: Normal
NCT ID: NCT04580810 Org: User:
Start: 07/07/21 End: 02/21/26 Due: 02/21/27

Understanding the Mechanism(s) of Action on the Modified Atkins Diet for Epilepsy: Human Brain Tissues

Phase: N/A Priority: Normal
NCT ID: NCT02565966 Org: User:
Start: 06/30/14 End: 10/01/19 Due: 10/01/20

Imiquimod for Breast Cancer Patients With Chest Wall Recurrence or Skin Metastases

Phase: N/A Priority: Normal
NCT ID: NCT00899574 Org: User:
Start: 05/31/09 End: 06/30/13 Due: 06/30/14

Double Blind Study of Vigabatrin for the Treatment of Cocaine Dependence

Phase: N/A Priority: Normal
NCT ID: NCT00527683 Org: User:
Start: 04/30/07 End: 11/30/07 Due: 11/30/08

Pembrolizumab (MK3475), Gemcitabine, and Concurrent Hypofractionated Radiation Therapy for Muscle-Invasive Urothelial Cancer of the Bladder

Phase: N/A Priority: Normal
NCT ID: NCT02621151 Org: User:
Start: 08/11/16 End: 12/31/25 Due: 12/31/26

Temozolomide,Thiotepa and Carboplatin With Autologous Stem Cell Rescue Followed by 13-cis-retinoic Acid in Patients With Recurrent/Refractory Malignant Brain Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00528437 Org: User:
Start: 10/31/05 End: 12/30/17 Due: 12/30/18

Effectiveness and Duration of Effect of Open Treatment in Attention Deficit Hyperactivity Disorder (ADHD) Patients Treated With Lisdexamfetamine Dimesylate(Vyvanse)

Phase: N/A Priority: Normal
NCT ID: NCT01070394 Org: User:
Start: 02/28/10 End: 07/31/12 Due: 07/31/13

PET/MR Assessment of Sipuleucel T Treatment for Metastatic Castration Resistant Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02042053 Org: User:
Start: 01/31/14 End: 10/31/15 Due: 10/31/16

Food Intake REstriction for Health OUtcome Support and Education (FIREHOUSE) Trial

Phase: N/A Priority: Normal
NCT ID: NCT03581006 Org: User:
Start: 11/12/18 End: 03/04/21 Due: 03/04/22

Buprenorphine Loading in the Emergency Department

Phase: N/A Priority: Normal
NCT ID: NCT04283500 Org: User:
Start: 11/01/20 End: 02/25/23 Due: 02/25/24